| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2297bd55d217e34e907af6dce15aeee3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40fa3f8618fa2849534d38014765976c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f10141ac5f791e5b04c0489b69a95e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ff8333c2eeec45ee5660b94cab587f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb3b126a1843d0f416086243b221a37 |
| publicationDate |
2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013267484-A1 |
| titleOfInvention |
Treatment of rheumatoid arthritis with masitinib |
| abstract |
The present invention relates to a tyrosine kinase inhibitor or a mast cell inhibitor, and in particular masitinib or a pharmaceutically acceptable salt thereof, for the treatment of human rheumatoid arthritis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018045258-A1 |
| priorityDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |